发明名称 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) |
摘要 |
FIELD: medicine. ^ SUBSTANCE: for the purpose of prediction of a virusological reponse in the patients suffering chronic combined HBV/HCV-infection, the antiviral therapy of chronic hepatitis B is associated with measuring the blood serum TNF- cytokine content prior to and during the therapy on the 4-5th week and on the 7-8th week. If the initial TNF- cytokine content increased in 1.5 times and more on the 4-5th week of the therapy to be decreased in 1.5 times and more from the initial level on the 7-8th week of the therapy, a good efficacy of the prescribed therapy is predicted. If the initial increased in 1.5 times and less on the 4-5th week or the TNF- value decreased in 1.5 times and less from the initial level on the 7-8th week of the therapy, the therapy is predicted to be ineffective. ^ EFFECT: method allows early prediction of the antiviral therapy effect in the 4-8th weeks from the beginning of the therapy. ^ 2 dwg, 2 ex |
申请公布号 |
RU2454666(C1) |
申请公布日期 |
2012.06.27 |
申请号 |
RU20110103823 |
申请日期 |
2011.02.02 |
申请人 |
GOSUDARSTVENNOE OBRAZOVATEL'NOE UCHREZHDENIE VYSSHEGO PROFESSIONAL'NOGO OBRAZOVANIJA "NIZHEGORODSKAJA GOSUDARSTVENNAJA MEDITSINSKAJA AKADEMIJA FEDERAL'NOGO AGENTSTVA PO ZDRAVOOKHRANENIJU I SOTSIAL'NOMU RAZVITIJU" (GOU VPO NIZHGMA ROSZDRAVA) |
发明人 |
SOBOLEVSKAJA OKSANA L'VOVNA;KOROCHKINA OL'GA VLADIMIROVNA |
分类号 |
G01N33/49 |
主分类号 |
G01N33/49 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|